Morning Headlines 4/29/16
Medicare’s new plan for paying doctors: 10 key takeaways
The Advisory Board Company recap’s yesterday’s MIPS and APM incentive proposed rule.
Leidos Holdings, Inc. Reports First Quarter Fiscal Year 2016 Results
Leidos reports Q1 results: revenue grew five percent to $1.31 billion vs. $1.25 billion in the same quarter last year, adjusted EPS $0.72 vs. $0.67. Executives announced that
Athenahealth, Inc. Q1 Profit Rises 47%
Athenahealth reports Q1 results: revenue climbed 24 percent to $256 million vs. 206 million in the same quarter last year, EPS $0.34 vs. $0.24, beating expectations on both.
FDA rejects antipyschotic drug/device combo
The FDA has rejected Proteus Digital Health’s request to embed smart sensors designed to track medication compliance into Otsuka’s antipsychotic medication Abilify.
Weird that Google can acknowledge its crowdsourced medical advice was wrong, but escape penalties for doing it wantonly at scale.